154 related articles for article (PubMed ID: 36864325)
1. Evaluation of Endoscopic Response Using Deep Neural Network in Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.
Matsuda S; Irino T; Kawakubo H; Takeuchi M; Nishimura E; Hisaoka K; Sano J; Kobayashi R; Fukuda K; Nakamura R; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2023 Jun; 30(6):3733-3742. PubMed ID: 36864325
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic Evaluation of Pathological Complete Response Using Deep Neural Network in Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy-Multicenter Retrospective Study from Four Japanese Esophageal Centers.
Matsuda S; Irino T; Okamura A; Mayanagi S; Booka E; Takeuchi M; Kawakubo H; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2023 Nov; 30(12):7472-7480. PubMed ID: 37543555
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of evaluating endoscopic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
Nagai Y; Yoshida N; Baba Y; Harada K; Imai K; Iwatsuki M; Karashima R; Koga Y; Nomoto D; Okadome K; Ishimoto T; Imamura Y; Watanabe M; Baba H
Dig Endosc; 2020 Jan; 32(1):39-48. PubMed ID: 31120560
[TBL] [Abstract][Full Text] [Related]
4. Application of artificial intelligence using convolutional neural networks in determining the invasion depth of esophageal squamous cell carcinoma.
Tokai Y; Yoshio T; Aoyama K; Horie Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Tsuchida T; Hirasawa T; Sakakibara Y; Yamada T; Yamaguchi S; Fujisaki J; Tada T
Esophagus; 2020 Jul; 17(3):250-256. PubMed ID: 31980977
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Endoscopic Response Evaluation to Predict the Distribution of Residual Tumor after Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Tsuji T; Aoyama J; Hirata Y; Takemura R; Mayanagi S; Irino T; Fukuda K; Nakamura R; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2022 Apr; 29(4):2673-2680. PubMed ID: 34812985
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma.
Kadota T; Abe S; Yoda Y; Yoshinaga S; Oda I; Kojima T; Kato K; Daiko H; Yano T
Dig Endosc; 2020 Mar; 32(3):337-345. PubMed ID: 31295769
[TBL] [Abstract][Full Text] [Related]
7. Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma.
Fujiwara Y; Lee S; Kishida S; Hashiba R; Gyobu K; Naka R; Nishiyama M; Ihara T; Takemura M; Osugi H
Int J Clin Oncol; 2018 Oct; 23(5):877-885. PubMed ID: 29752605
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and clinical validation of an artificial intelligence YOLOv51 model for the detection of precancerous lesions and superficial esophageal cancer in endoscopic procedure].
Wang SX; Ke Y; Liu YM; Liu SY; Song SB; He S; Zhang YM; Dou LZ; Liu Y; Liu XD; Wu HR; Su FX; Zhang FY; Zhang W; Wang GQ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):395-401. PubMed ID: 35615795
[No Abstract] [Full Text] [Related]
10. Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists.
Nakagawa K; Ishihara R; Aoyama K; Ohmori M; Nakahira H; Matsuura N; Shichijo S; Nishida T; Yamada T; Yamaguchi S; Ogiyama H; Egawa S; Kishida O; Tada T
Gastrointest Endosc; 2019 Sep; 90(3):407-414. PubMed ID: 31077698
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence for detecting superficial esophageal squamous cell carcinoma under multiple endoscopic imaging modalities: A multicenter study.
Yuan XL; Guo LJ; Liu W; Zeng XH; Mou Y; Bai S; Pan ZG; Zhang T; Pu WF; Wen C; Wang J; Zhou ZD; Feng J; Hu B
J Gastroenterol Hepatol; 2022 Jan; 37(1):169-178. PubMed ID: 34532890
[TBL] [Abstract][Full Text] [Related]
12. Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance.
Shiroma S; Yoshio T; Kato Y; Horie Y; Namikawa K; Tokai Y; Yoshimizu S; Yoshizawa N; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Akazawa N; Akiyama J; Tada T; Fujisaki J
Sci Rep; 2021 Apr; 11(1):7759. PubMed ID: 33833355
[TBL] [Abstract][Full Text] [Related]
13. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
Schneider PM; Metzger R; Schaefer H; Baumgarten F; Vallbohmer D; Brabender J; Wolfgarten E; Bollschweiler E; Baldus SE; Dienes HP; Hoelscher AH
Ann Surg; 2008 Dec; 248(6):902-8. PubMed ID: 19092334
[TBL] [Abstract][Full Text] [Related]
14. Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K; Yamashita K; Nakagawa A; Yamada K; Watanabe A; Mukohyama J; Saito M; Fujita M; Takiguchi G; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2021 Aug; 41(8):4117-4126. PubMed ID: 34281882
[TBL] [Abstract][Full Text] [Related]
15. A single-center prospective study evaluating the usefulness of artificial intelligence for the diagnosis of esophageal squamous cell carcinoma in a real-time setting.
Tani Y; Ishihara R; Inoue T; Okubo Y; Kawakami Y; Matsueda K; Miyake M; Yoshii S; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Kato Y; Tada T
BMC Gastroenterol; 2023 May; 23(1):184. PubMed ID: 37231330
[TBL] [Abstract][Full Text] [Related]
16. Impact of CT-assessed changes in tumor size after neoadjuvant chemotherapy on pathological response and survival of patients with esophageal squamous cell carcinoma.
Matsumoto S; Wakatsuki K; Nakade H; Kunishige T; Miyao S; Tsujimoto A; Tatsumi T; Sho M
Langenbecks Arch Surg; 2022 May; 407(3):965-974. PubMed ID: 34989856
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.
Tian D; Zhang L; Wang Y; Chen L; Zhang KP; Zhou Y; Wen HY; Fu MY
Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30247659
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.
Hirahara N; Matsubara T; Kaji S; Hayashi H; Kawakami K; Sasaki Y; Takao S; Takao N; Hyakudomi R; Yamamoto T; Tajima Y
BMC Cancer; 2022 Jun; 22(1):718. PubMed ID: 35768866
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
